Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IFN-beta-1a in Moderately Active Ulcerative Colitis
NCT00303381Phase 2Completed
- Sponsor
- EMD Serono
- Start
- Dec 2001
- Primary completion
- Jan 2003
- Modality
- Cytokines & Interferons
- Countries
- 7
01
Overview
Phase 2, randomised, double-blind trial of interferon beta-1a in ulcerative colitis (UC) (3 arms), sponsored by EMD Serono. Primary endpoint: Percentage of subjects with endoscopically confirmed remission at 12 weeks. Started Dec 2001; status: completed.
02
Drugs
interferon beta-1a
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT00303381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00303381.